Gur Roshwalb
Overview
Gur Roshwalb received an average of $4M in total compensation, including $354K in salary, at Akari Therapeutics Plc between 2014 and 2015.
Source: SEC filing on April 28, 2016.
Related executives
We found six more executives who work or worked at Akari Therapeutics Plc.
Rachelle Jacques
Akari Therapeutics Plc
Chief Executive Officer
Wendy DiCicco
Akari Therapeutics Plc
Chief Financial Officer
Torsten Hombeck
Akari Therapeutics Plc
Chief Financial Officer
Clive Richardson
Akari Therapeutics Plc
Chief Operating Officer
Dov Elefant
Akari Therapeutics Plc
Chief Financial Officer
Pablo Jimenez
Akari Therapeutics Plc